DVA - DaVita HealthCare Partners Inc logo

DaVita HealthCare Partners Inc

DVA

DaVita provides kidney dialysis services for patients with chronic kidney failure in the U.S. It operates dialysis centers, offers lab services, integrated care, clinical research, and disease management, alongside comprehensive kidney care solutions.

โš•๏ธ Healthcare NYSE Listed 1995 $ USD
$1,000 invested 5 years ago โ†’$1,466today

Score Overview

1 Year
Score
Net Growth23.90%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth2.69%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score6.0
Net Growth-5.43%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth20.58%
Rev Trend80%
Revenue Consistencyโ€”
10 Years
Score
Net Growth5.16%
Net Trend50%
Net Income Consistency
Rev Growth-4.99%
Rev Trend70%
Revenue Consistency
20 Years
Score5.7
Net Growth219.41%
Net Trend60%
Net Income Consistency
Rev Growth187.04%
Rev Trend85%
Revenue Consistency
30 Years
Score
Net Growth34x
Net Trend67%
Net Income Consistency
Rev Growth51x
Rev Trend90%
Revenue Consistency
All Time
Score
Net Growth151x
Net Trend68%
Net Income Consistency
Rev Growth156x
Rev Trend90%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where DaVita HealthCare Partners Inc has ranked, year by year

Measure
Fundamentals Window

Showing 1 year ranking history by HDB Score.

Reached the top 50 on HDB Score in 1 year, the longest run being 1 in a row โ€” but not in 2021.

  • DVA

2001: 29.4% ยท 2021: 43.9% ยท free through 2021 ยท longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-09-28
$ 178.07โ€”
1 Year2025-09-26
$ 130.8036.14%
5 Years2021-09-28
$ 121.4346.64%
10 Years2016-09-28
$ 66.21168.95%
20 Years2006-09-28
$ 28.846x
30 Years1996-09-27
$ 7.8022x
All Time1995-10-31
$ 4.0843x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 14.00B$ 925M$ 688M
2025$ 13.64B$ 746M$ 782M
2024$ 12.81B$ 936M$ 845M
2023$ 12.14B$ 691M$ 391M
2022$ 11.60B$ 560M$ 321M
2021$ 11.61B$ 978M$ 484M
2020$ 11.55B$ 773M$ 345M
2019$ 11.38B$ 810M$ 1.11B
2018$ 11.40B$ 159M$ 325M
2017$ 10.87B$ 663M$ 551M
2016$ 14.74B$ 879M$ 1.22B
2015$ 13.78B$ 269M$ 1.90B
2014$ 12.79B$ 723M$ 1.30B
2013$ 11.76B$ 633M$ 953M
2012$ 8.18B$ 536M$ 540M
2011$ 6.79B$ 478M$ 411M
2010$ 6.44B$ 405M$ 883M
2009$ 6.10B$ 422M$ 565M
2008$ 5.66B$ 374M$ 446M
2007$ 5.26B$ 381M$ 487M
2006$ 4.88B$ 289M$ 310M
2005$ 2.97B$ 228M$ 431M
2004$ 2.29B$ 222M$ 251M
2003$ 2.04B$ 175M$ 61M
2002$ 1.85B$ 157M$ 96M
2001$ 1.65B$ 137M$ 36M
2000$ 1.48B$ 13M$ 31M
1999$ 1.44B-$ 147M$ 107M
1998$ 1.20B-$ 9M$ 41M
1997$ 438M$ 45M$ 5M
1996$ 272M$ 26M$ 19M
IPO1995$ 89M$ 6M$ 30M
DVA - DaVita HealthCare Partners Inc logo

DaVita HealthCare Partners Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 11.55B to $ 13.64B and net income declined from $ 773M to $ 746M. Revenue increased in 4 of those 5 years; net income in 3.

Across DaVita HealthCare Partners Inc's full reported history, from 1995 to 2025, revenue grew from $ 89M to $ 13.64B and net income grew from $ 6M to $ 746M. Revenue increased in 90% of the years measured; net income in 68%.

DaVita HealthCare Partners Inc currently holds a 20-year HDB Score of 5.7 out of 10. How the HDB Score is calculated.

Membership

Continue DVAโ€™s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,816 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies